Skip to main content
TipRanks
Go Ultimate75% OFF

Center Laboratories, Inc. (4123) Financial Statements

Center Laboratories, Inc. Financial Overview

Center Laboratories, Inc.'s market cap is currently NT$22.38B. The company's EPS TTM is NT$1.19; its P/E ratio is 23.82; and it has a dividend yield of 6.15%. Center Laboratories, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total RevenueNT$ 1.52BNT$ 1.62BNT$ 1.39BNT$ 767.72MNT$ 500.11M
Gross ProfitNT$ 621.26MNT$ 748.95MNT$ 618.09MNT$ 406.27MNT$ 259.66M
Operating IncomeNT$ -361.62MNT$ 234.32MNT$ 78.54MNT$ 131.94MNT$ 1.04B
EBITDANT$ 11.95BNT$ -232.41MNT$ -765.79MNT$ 232.50MNT$ 2.73B
Net IncomeNT$ 9.32BNT$ -1.10BNT$ -995.42MNT$ -575.62MNT$ 1.82B
Balance Sheet
Cash & Short-Term InvestmentsNT$ 974.21MNT$ 3.23BNT$ 4.55BNT$ 2.56BNT$ 5.09B
Total AssetsNT$ 34.63BNT$ 25.54BNT$ 27.00BNT$ 25.19BNT$ 30.44B
Total DebtNT$ 4.70BNT$ 6.53BNT$ 5.62BNT$ 3.47BNT$ 5.27B
Net DebtNT$ 4.47BNT$ 5.09BNT$ 3.92BNT$ 2.68BNT$ 5.00B
Total LiabilitiesNT$ 8.14BNT$ 7.48BNT$ 6.79BNT$ 5.94BNT$ 9.35B
Stockholders' EquityNT$ 26.49BNT$ 18.05BNT$ 19.76BNT$ 19.25BNT$ 18.94B
Cash Flow
Free Cash FlowNT$ -181.05MNT$ 234.89MNT$ -1.14BNT$ -197.43MNT$ -364.79M
Operating Cash FlowNT$ 27.16MNT$ 415.71MNT$ -963.44MNT$ -189.88MNT$ -358.14M
Investing Cash FlowNT$ 1.65BNT$ -757.51MNT$ -129.01MNT$ 5.18BNT$ -655.88M
Financing Cash FlowNT$ -2.88BNT$ 79.09MNT$ 2.00BNT$ -4.46BNT$ 358.10M

Currency in TWD

Center Laboratories, Inc. Earnings and Revenue History

-12B012B24B-400 %0 %400 %800 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Center Laboratories, Inc. Liabilities to Assets

015B30B45B15 %30 %45 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Center Laboratories, Inc. Cash Flow

-5B-2.5B02.5B5B7.5B201720182019202020212022202320242025OperatingInvestingFinancing

Center Laboratories, Inc. Forecast EPS vs Actual EPS

-20-15-10-5051015Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss